EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Understanding Parkinson disease in Spain: Genetic and clinical insights

Pilar Gómez-Garre iD, Miguel Martín-Bórnez iD, Laura Muñoz-Delgado, Rafael Díaz-Belloso iD, María Teresa Periñán, Marta Bonilla-Toribio, Dolores Buiza-Rueda, Daniel Macías-García iD, Silvia Jesús, Astrid Adarmes-Gómez, Elena Ojeda, Antonio Luque-Ambrosiani und 4 weitere

European Journal of Neurology · 2025

DOI: 10.1111/ene.16499 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neurology, 2025. Verfasst von Pilar Gómez-Garre und 15 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Trastornos del Movimiento, Servicio de Neurología, Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/CSIC/U…. Hauptthemen laut MEDLINE: Parkinson Disease, Leucine-Rich Repeat Serine-Threonine Protein Kinase-2. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Consejería de Economía, Innovación, Ciencia y Empleo de la Junta de Andalucía, Consejería de Salud y Bienestar Social de la Junta de Andalucía, Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and purpose Parkinson disease (PD) is a complex and heterogeneous neurodegenerative disorder with a broad spectrum of clinical manifestations, determined by a complex interplay of environmental and genetic factors. This study aimed to investigate genetic variants associated with PD and assess their impact on the disease phenotype through genotype–phenotype correlations.

Methods

We employed a targeted resequencing panel to analyze 27 genes linked to PD in a cohort of 1185 PD patients from southern Spain. Variants were categorized based on the American College of Medical Genetics and Genomics pathogenicity criteria. Demographic and clinical data were also collected.

Results

Among the patients analyzed, 13.5% carried potential disease‐causing pathogenic or likely pathogenic variants in 12 different genes, indicating significant genetic heterogeneity. The most frequently affected genes were LRRK2 , PRKN , and GBA1 (accounting for 72.1% of positive cases). Sex‐specific differences were observed, with a higher proportion of female patients carrying LRRK2 variants. Differences in age at onset and clinical features were also observed among the different mutated genes. Notably, variants in genes associated with atypical parkinsonism presented distinct clinical presentations, highlighting the importance of genetic factors in the differential diagnosis.

Conclusions

Our study provides valuable information on the genetic landscape of PD and its clinical manifestations. The observed genotype–phenotype correlations, along with sex‐specific differences, emphasize the complexity of PD pathogenesis, underlining the importance of personalized approaches to PD diagnosis and treatment. Further investigations into genetic interactions and population‐specific effects are warranted to enhance our understanding of PD etiology and improve patient care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseLeucine-Rich Repeat Serine-Threonine Protein Kinase-2HumansFemaleMaleSpainAgedMiddle AgedGenetic Association StudiesAged, 80 and overAdultGlucosylceramidaseGenetic Predisposition to DiseaseMutationCohort Studies

Stichwörter der Autor:innen

Parkinson diseaseclinical insightsgenetic insightstargeted sequencing

Substanzen

Leucine-Rich Repeat Serine-Threonine Protein Kinase-2LRRK2 protein, humanGlucosylceramidaseGBA protein, human

Autor:innen und Institutionen

  • Unidad de Trastornos del Movimiento, Servicio de Neurología, Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.
  • Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain.
  • Departamento de Medicina, Facultad de Medicina, Universidad de Sevilla, Seville, Spain.
  • Centre for Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.

ORCID-Profile: Pilar Gómez-Garre, Miguel Martín-Bórnez, Rafael Díaz-Belloso, Daniel Macías-García, Pablo Mir

Förderung

  • Consejería de Economía, Innovación, Ciencia y Empleo de la Junta de Andalucía
  • Consejería de Salud y Bienestar Social de la Junta de Andalucía
  • Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union
  • Instituto de Salud Carlos III

Zitieren

APA

Gómez-Garre, P., Martín-Bórnez, M., Muñoz-Delgado, L., Díaz-Belloso, R., Periñán, M. T., Bonilla-Toribio, M., Buiza-Rueda, D., Macías-García, D., Jesús, S., Adarmes-Gómez, A., Ojeda, E., Luque-Ambrosiani, A., García-Díaz, S., Sánchez, R. P., Carrillo, F., & Mir, P. (2025). Understanding Parkinson disease in Spain: Genetic and clinical insights. European Journal of Neurology. https://doi.org/10.1111/ene.16499

Vancouver

Gómez-Garre P, Martín-Bórnez M, Muñoz-Delgado L, Díaz-Belloso R, Periñán MT, Bonilla-Toribio M, et al. Understanding Parkinson disease in Spain: Genetic and clinical insights. European Journal of Neurology. 2025. doi:10.1111/ene.16499

BibTeX
@article{GmezGarre2025,
  author = {Gómez-Garre, Pilar and Martín-Bórnez, Miguel and Muñoz-Delgado, Laura and Díaz-Belloso, Rafael and Periñán, María Teresa and Bonilla-Toribio, Marta and Buiza-Rueda, Dolores and Macías-García, Daniel and Jesús, Silvia and Adarmes-Gómez, Astrid and Ojeda, Elena and Luque-Ambrosiani, Antonio and García-Díaz, Sergio and Sánchez, Rocío Pineda and Carrillo, Fátima and Mir, Pablo},
  title = {Understanding Parkinson disease in Spain: Genetic and clinical insights},
  journal = {European Journal of Neurology},
  year = {2025},
  doi = {10.1111/ene.16499}
}
Kostenlos starten →